Stay updated with the latest news and research from CarelonRx

The CarelonRx Drug and Biologic Pipeline Update is published each quarter to keep you informed about upcoming Food and Drug Administration (FDA) approvals. This newsletter analyzes drugs and biologics in development and other clinical topics of interest.

CarelonRx's DrugInsights provides a quarterly summary of FDA-approved new molecular entities, formulations, and indications. We continue to closely monitor the FDA landscape to provide you with an understanding of the current drug and biologic market.

This monthly newsletter provides short summaries and links to all the stories and clinical reports made available on carelonrx.com throughout the month.